Have a feature idea you'd love to see implemented?
Let us know!
HROW Harrow Health Inc
Price (delayed)
$50.99
Market cap
$1.81B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.96
Enterprise value
$1.93B
Harrow Health, Inc. owns a portfolio of ophthalmic pharmaceutical businesses, including ImprimisRx, the nation's leading ophthalmology outsourcing facility and pharmaceutical compounding business. The company holds large equity positions in Eton
Highlights
HROW's gross profit has soared by 53% YoY and by 13% QoQ
HROW's revenue has surged by 50% year-on-year and by 11% since the previous quarter
Harrow Health's equity has soared by 161% YoY but it has decreased by 3.4% from the previous quarter
Harrow Health's quick ratio has increased by 11% YoY but it has decreased by 8% from the previous quarter
Harrow Health's net income has plunged by 106% YoY and by 7% from the previous quarter
The EPS has dropped by 71% year-on-year and by 4.3% since the previous quarter
Key stats
What are the main financial stats of HROW
Market
Valuations
Earnings
Shares outstanding
35.48M
Market cap
$1.81B
Enterprise value
$1.93B
Price to earnings (P/E)
N/A
Price to book (P/B)
30.82
Price to sales (P/S)
11.78
EV/EBIT
N/A
EV/EBITDA
783.54
EV/Sales
12.52
Revenue
$154.15M
EBIT
-$10.16M
EBITDA
$2.46M
Free cash flow
-$1.04M
Per share
Balance sheet
Liquidity
EPS
-$0.96
Free cash flow per share
-$0.03
Book value per share
$1.65
Revenue per share
$4.33
TBVPS
$4.2
Total assets
$306.63M
Total liabilities
$248.45M
Debt
$192.33M
Equity
$58.53M
Working capital
$85.84M
Debt to equity
3.29
Current ratio
2.6
Quick ratio
2.3
Net debt/EBITDA
49.26
Margins
Efficiency
Dividend
EBITDA margin
1.6%
Gross margin
71.2%
Net margin
-21.8%
Operating margin
-5.5%
Return on assets
-11.2%
Return on equity
-50.6%
Return on invested capital
-4.6%
Return on capital employed
-4%
Return on sales
-6.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HROW stock price
How has the Harrow Health stock price performed over time
Intraday
-0.02%
1 week
11.14%
1 month
29.68%
1 year
257.07%
YTD
355.27%
QTD
13.41%
Financial performance
How have Harrow Health's revenue and profit performed over time
Revenue
$154.15M
Gross profit
$109.69M
Operating income
-$8.53M
Net income
-$33.58M
Gross margin
71.2%
Net margin
-21.8%
Harrow Health's net income has plunged by 106% YoY and by 7% from the previous quarter
HROW's gross profit has soared by 53% YoY and by 13% QoQ
HROW's revenue has surged by 50% year-on-year and by 11% since the previous quarter
Harrow Health's net margin has decreased by 38% YoY but it has increased by 3.5% from the previous quarter
Growth
What is Harrow Health's growth rate over time
Valuation
What is Harrow Health stock price valuation
P/E
N/A
P/B
30.82
P/S
11.78
EV/EBIT
N/A
EV/EBITDA
783.54
EV/Sales
12.52
The EPS has dropped by 71% year-on-year and by 4.3% since the previous quarter
Harrow Health's equity has soared by 161% YoY but it has decreased by 3.4% from the previous quarter
The stock's price to book (P/B) is 15% more than its 5-year quarterly average of 26.8
HROW's revenue has surged by 50% year-on-year and by 11% since the previous quarter
Efficiency
How efficient is Harrow Health business performance
The ROIC has plunged by 188% YoY and by 18% from the previous quarter
The return on sales has dropped by 175% year-on-year and by 10% since the previous quarter
Harrow Health's return on equity has increased by 43% YoY and by 7% QoQ
The return on assets has declined by 20% year-on-year
Dividends
What is HROW's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HROW.
Financial health
How did Harrow Health financials performed over time
The total assets is 23% greater than the total liabilities
The total assets is up by 37% year-on-year and by 3.8% since the previous quarter
HROW's total liabilities is up by 23% year-on-year and by 6% since the previous quarter
Harrow Health's equity has soared by 161% YoY but it has decreased by 3.4% from the previous quarter
The debt to equity has plunged by 58% YoY but it has grown by 4.1% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.